RANP2

Across TCGA pan-cancer cohorts, RANP2 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RANP2 data layer.

The strongest signal is observed in sarcoma (SARC), where higher RANP2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RANP2 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

SARC, THYM, and LUSC are the cancer types where RANP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	OS	Tertile	All	0.213	0.561	<.001	45	view →
THYM	OS	Tertile	III,IV	0.229	1.000	<.001	27	view →
LUSC	DFS	Quartile	All	0.583	0.851	<.001	19	view →
KIRC	DFS	Tertile	II,III,IV	0.298	0.576	.004	18	view →
PAAD	OS	Tertile	II,III,IV	0.204	0.644	<.001	18	view →
DLBC	DFS	Tertile	II,III,IV	0.382	0.951	.008	18	view →
THCA	OS	Tertile	IV	0.579	1.000	<.001	18	view →
LIHC	DFS	Tertile	All	0.283	0.451	.018	15	view →
ACC	OS	Quartile	II,III,IV	0.568	0.817	.013	11	view →
READ	OS	Quartile	All	0.291	0.804	.010	7	view →
ESCA	OS	Tertile	II,III,IV	1.000	0.453	.034	6	view →
LGG	OS	Tertile	All	0.260	0.483	.012	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RANP2–SARC (OS)

Open the SARC breakdown →